ORIC Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORIC research report →
About the company
ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates.
- CEO
- Jacob Chacko
- IPO
- 2020
- Employees
- 122
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $1.20B
- P/E
- -8.08
- P/S
- 0.00
- P/B
- 2.95
- EV/EBITDA
- -8.59
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -35.33%
- ROIC
- -35.50%
- Revenue
- $0 · 0.00%
- Net Income
- $-129,468,000 · -1.27%
- EPS
- $-1.47 · 19.67%
- Op Income
- $-143,004,000
- FCF YoY
- -0.20%
- 52W High
- $14.93
- 52W Low
- $7.23
- 50D MA
- $8.95
- 200D MA
- $10.67
- Beta
- 1.01
- Avg Volume
- 1.64M
Get TickerSpark's AI analysis on ORIC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 24, 26 | Piscitelli Dominic | other | 52,000 |
| Feb 24, 26 | Piscitelli Dominic | other | 52,000 |
| Feb 24, 26 | Piscitelli Dominic | sell | 52,000 |
| Jan 16, 26 | Heyman Richard A. | sell | 3,200 |
| Jan 16, 26 | Heyman Richard A. | sell | 3,500 |
| Jan 2, 26 | You Angie | other | 40,000 |
| Jan 2, 26 | Kunkel Lori Anne | other | 40,000 |
| Jan 2, 26 | Hoerter Steven L. | other | 40,000 |
| Jan 2, 26 | Heyman Richard A. | other | 40,000 |
| Jan 2, 26 | Dier Mardi | other | 40,000 |
Our ORIC coverage
Recent articles, reports, and earnings notes.
No research on ORIC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ORIC report →Similar companies
Peers in the same neighborhood.